Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Anticancer Research
|
July 5, 2020
Identification of Biomarkers for Non-small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor
Sousuke Kubo, Nobuaki Kobayashi, Kohei Somekawa, et al.
Therapeutic Advances in Medical Oncology
|
February 17, 2022
Adverse events induced by nivolumab and ipilimumab combination regimens
Kohei Somekawa, Nobuyuki Horita, Ayami Kaneko, et al.
Translational Lung Cancer Research
|
August 13, 2025
MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer
Ayami Kaneko, Nobuaki Kobayashi, Sousuke Kubo, et al.
Thoracic Cancer
|
May 4, 2021
T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer
Chisato Kamimaki, Nobuaki Kobayashi, Momo Hirata, et al.
Anticancer Research
|
June 29, 2026
Nab-paclitaxel or Paclitaxel Treatment for Relapsed Small Cell Lung Cancer: A Single-arm Meta-analysis
Sousuke Kubo, Kohei Somekawa, Satoshi Nagaoka, et al.
Scientific Reports
|
July 2, 2024
Geographic and economic influences on benralizumab prescribing for severe asthma in Japan
Nobuaki Kobayashi, Hiromi Matsumoto, Kohei Somekawa, et al.
Thoracic Cancer
|
October 26, 2021
Diagnostic utility of transbronchial biopsy for Hodgkin's lymphoma: A case study
Miki Hoshi, Nobuaki Kobayashi, Katsushi Tanaka, et al.
Cancers
|
November 14, 2023
Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes
Nobuaki Kobayashi, Kenji Miura, Ayami Kaneko, et al.
Translational Lung Cancer Research
|
August 13, 2025
Real-world efficacy of immune checkpoint inhibitors in PD-L1 negative non-small cell lung cancer: a multicenter retrospective study
Suguru Muraoka, Nobuaki Kobayashi, Ayami Kaneko, et al.
Plos One
|
August 1, 2024
High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse
Hiromi Matsumoto, Taichi Fukushima, Nobuaki Kobayashi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Anticancer Research
|
July 5, 2020
Identification of Biomarkers for Non-small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor
Sousuke Kubo, Nobuaki Kobayashi, Kohei Somekawa, et al.
Therapeutic Advances in Medical Oncology
|
February 17, 2022
Adverse events induced by nivolumab and ipilimumab combination regimens
Kohei Somekawa, Nobuyuki Horita, Ayami Kaneko, et al.
Translational Lung Cancer Research
|
August 13, 2025
MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer
Ayami Kaneko, Nobuaki Kobayashi, Sousuke Kubo, et al.
Thoracic Cancer
|
May 4, 2021
T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer
Chisato Kamimaki, Nobuaki Kobayashi, Momo Hirata, et al.
Anticancer Research
|
June 29, 2026
Nab-paclitaxel or Paclitaxel Treatment for Relapsed Small Cell Lung Cancer: A Single-arm Meta-analysis
Sousuke Kubo, Kohei Somekawa, Satoshi Nagaoka, et al.
Scientific Reports
|
July 2, 2024
Geographic and economic influences on benralizumab prescribing for severe asthma in Japan
Nobuaki Kobayashi, Hiromi Matsumoto, Kohei Somekawa, et al.
Thoracic Cancer
|
October 26, 2021
Diagnostic utility of transbronchial biopsy for Hodgkin's lymphoma: A case study
Miki Hoshi, Nobuaki Kobayashi, Katsushi Tanaka, et al.
Cancers
|
November 14, 2023
Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes
Nobuaki Kobayashi, Kenji Miura, Ayami Kaneko, et al.
Translational Lung Cancer Research
|
August 13, 2025
Real-world efficacy of immune checkpoint inhibitors in PD-L1 negative non-small cell lung cancer: a multicenter retrospective study
Suguru Muraoka, Nobuaki Kobayashi, Ayami Kaneko, et al.
Plos One
|
August 1, 2024
High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse
Hiromi Matsumoto, Taichi Fukushima, Nobuaki Kobayashi, et al.
Page
of 3